acetylleucyl-leucyl-norleucinal has been researched along with sirolimus in 5 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
---|---|---|---|---|---|
321 | 0 | 53 | 20,711 | 2,368 | 11,516 |
Protein | Taxonomy | acetylleucyl-leucyl-norleucinal (IC50) | sirolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
Joly, A; Kohler, NG; Meyer, S | 1 |
Desrivières, S; Ferrari, S; Hashemolhosseini, S; Mercep, L; Morley, SJ; Nagamine, Y | 1 |
Dong, J; Hung, MC; Jian, W; Meric-Bernstam, F; Mills, GB; Mondesire, WH; Peng, J; Zhang, H | 1 |
5 other study(ies) available for acetylleucyl-leucyl-norleucinal and sirolimus
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.
Topics: Animals; Brain; Cattle; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Leupeptins; Lipopolysaccharides; Multienzyme Complexes; NF-kappa B; NF-kappa B p50 Subunit; Polyenes; Proteasome Endopeptidase Complex; Protein Precursors; Proto-Oncogene Proteins; Sirolimus; Transcription Factor RelB; Transcription Factors; Tumor Necrosis Factor-alpha | 1997 |
Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.
Topics: 3T3 Cells; Animals; Apoptosis; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; G1 Phase; Heat-Shock Proteins; Immunosuppressive Agents; Leupeptins; Mice; Microtubule-Associated Proteins; Phosphorylation; Polyenes; Retinoblastoma Protein; Ribosomal Protein S6 Kinases; RNA, Messenger; Sirolimus; Tacrolimus Binding Proteins; Transcription, Genetic; Tumor Suppressor Proteins | 1998 |
Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Topics: Aminophenols; Antibiotics, Antineoplastic; Antimanic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cyclin D1; Cysteine Proteinase Inhibitors; Down-Regulation; Drug Resistance, Neoplasm; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Half-Life; Humans; Indoles; Leupeptins; Lithium Chloride; Maleimides; Mitochondria; NF-kappa B; Paclitaxel; Proteasome Inhibitors; Sirolimus | 2005 |